Skip to main content

. 1952 Jun;36(6):281–302. doi: 10.1136/bjo.36.6.281

Retrolental Fibroplasia ^{^*}

Early Development and the Effect of ACTH in Treatment

C A Brown ¹, Beryl Corner ¹

PMCID: PMC1323935 PMID: 14925301

281

Images in this article

Fig. 1
on p.293

Fig. 2
on p.296

Fig. 3
on p.298-1

Fig. 4
on p.298-2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BIEGEL A. C. Effect of cortisone on horse serum uveitis in rabbits. AMA Arch Ophthalmol. 1951 Mar;45(3):258–273. doi: 10.1001/archopht.1951.01700010264003. [DOI] [PubMed] [Google Scholar]
CAMPBELL K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust. 1951 Jul 14;2(2):48–50. [PubMed] [Google Scholar]
COOK C., MacDONALD R. K. Effect of cortisone on the permeability of the blood-aqueous barrier to fluorescein. Br J Ophthalmol. 1951 Nov;35(11):730–740. doi: 10.1136/bjo.35.11.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
DUKE-ELDER S. The clinical value of cortisone and ACTH in ocular disease; a preliminary assessment for the Medical Research Council. Br J Ophthalmol. 1951 Nov;35(11):637–671. doi: 10.1136/bjo.35.11.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
FITZGERALD J. R., BELLOWS J. G., DONEGAN J. M., GAMBLE R. C., KRAUSE A. C., MANN W. A., PEARLMAN M. D., ZEKMAN T. N. Early clinical results of ACTH and cortisone treatment of ocular diseases. AMA Arch Ophthalmol. 1951 Mar;45(3):320–323. doi: 10.1001/archopht.1951.01700010326007. [DOI] [PubMed] [Google Scholar]
KING M. J. Retrolental fibroplasia; a clinical study of 238 cases. Arch Ophthal. 1950 Apr;43(4):694–711. [PubMed] [Google Scholar]
KINSEY V. E., CHISHOLM J. F., Jr Retrolental fibroplasia; evaluation of several changes in dietary supplements of premature infants with respect to the incidence of the disease. Am J Ophthalmol. 1951 Sep;34(9):1259–1268. [PubMed] [Google Scholar]
LELONG M., RENARD G., ROSSIER A., LEMASSON C., MICHELIN J. La rétinopathie des prématurés (fibroplasie rétrolentale); documents iconographiques. Presse Med. 1951 May 23;59(35):705–708. [PubMed] [Google Scholar]
McLEAN J. M., GORDON D. M., KOTEEN H. Clinical experiences with ACTH and cortisone in ocular diseases. Trans Am Acad Ophthalmol Otolaryngol. 1951 May-Jun;55:565–572. [PubMed] [Google Scholar]
SCHEIE H. G., TYNER G. S., BUESSELER J. A., ALFANO J. E. Adrenocorticotropic hormone ACTH and cortisone in ophthalmology; report of cases. AMA Arch Ophthalmol. 1951 Mar;45(3):301–316. doi: 10.1001/archopht.1951.01700010307005. [DOI] [PubMed] [Google Scholar]
WOODS A. C. Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease. Am J Ophthalmol. 1950 Sep;33(9):1325–1349. doi: 10.1016/0002-9394(50)91827-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES